Liquidia (NASDAQ:LQDA) CEO Roger Jeffs Sells 25,000 Shares

Liquidia Corporation (NASDAQ:LQDA) CEO Roger Jeffs sold 25,000 shares of the stock in a transaction that occurred on Wednesday, April 15th. The shares were sold at an average price of $40.14, for a total value of $1,003,500.00. Following the transaction, the chief executive officer owned 1,466,934 shares in the company, valued at $58,882,730.76. This trade represents a 1.68% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Roger Jeffs also recently made the following trade(s):

• On Tuesday, April 14th, Roger Jeffs sold 3,300 shares of Liquidia stock. The shares were sold at an average price of $40.00, for a total value of $132,000.00.
• On Monday, April 13th, Roger Jeffs sold 32,744 shares of Liquidia stock. The shares were sold at an average price of $38.37, for a total value of $1,256,387.28.
• On Friday, April 10th, Roger Jeffs sold 21,433 shares of Liquidia stock. The shares were sold at an average price of $40.12, for a total value of $859,891.96.
• On Thursday, April 9th, Roger Jeffs sold 25,000 shares of Liquidia stock. The shares were sold at an average price of $40.12, for a total value of $1,003,000.00.

Liquidia Trading Up 3.2%

Shares of LQDA stock opened at $41.40 on Friday. The stock’s fifty day moving average is $36.63 and its two-hundred day moving average is $33.14. The company has a debt-to-equity ratio of 2.97, a quick ratio of 1.84 and a current ratio of 2.01. The firm has a market capitalization of $3.65 billion, a P/E ratio of -49.88 and a beta of 0.45. Liquidia Corporation has a fifty-two week low of $11.85 and a fifty-two week high of $46.67.

Liquidia (NASDAQ:LQDA) last announced its quarterly earnings data on Thursday, March 5th. The company reported $0.15 earnings per share for the quarter, beating analysts’ consensus estimates of $0.08 by $0.07. The company had revenue of $92.02 million for the quarter, compared to analyst estimates of $87.49 million. Liquidia had a negative return on equity of 209.33% and a negative net margin of 43.53%.The business’s revenue was up 3072.4% compared to the same quarter last year. Research analysts expect that Liquidia Corporation will post -1.51 earnings per share for the current fiscal year.

Institutional Trading of Liquidia

A number of hedge funds and other institutional investors have recently modified their holdings of LQDA. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in shares of Liquidia by 4.7% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 37,681 shares of the company’s stock worth $556,000 after acquiring an additional 1,700 shares during the last quarter. Goldman Sachs Group Inc. increased its stake in shares of Liquidia by 10.7% in the 1st quarter. Goldman Sachs Group Inc. now owns 861,231 shares of the company’s stock worth $12,703,000 after acquiring an additional 82,955 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its stake in shares of Liquidia by 15.2% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 121,756 shares of the company’s stock worth $1,796,000 after acquiring an additional 16,022 shares during the last quarter. Creative Planning increased its stake in shares of Liquidia by 40.7% in the 2nd quarter. Creative Planning now owns 26,840 shares of the company’s stock worth $334,000 after acquiring an additional 7,765 shares during the last quarter. Finally, Legal & General Group Plc increased its stake in shares of Liquidia by 13.4% in the 2nd quarter. Legal & General Group Plc now owns 94,152 shares of the company’s stock worth $1,174,000 after acquiring an additional 11,111 shares during the last quarter. 64.54% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on the company. Wells Fargo & Company raised their price objective on Liquidia from $44.00 to $51.00 and gave the company an “overweight” rating in a report on Monday, March 23rd. Jefferies Financial Group raised their price objective on Liquidia from $45.00 to $55.00 and gave the company a “buy” rating in a report on Tuesday, January 13th. HC Wainwright raised their price objective on Liquidia from $50.00 to $55.00 and gave the company a “buy” rating in a report on Friday, March 6th. Needham & Company LLC raised their price objective on Liquidia from $52.00 to $54.00 and gave the company a “buy” rating in a report on Thursday, March 5th. Finally, BTIG Research raised their price objective on Liquidia from $49.00 to $50.00 and gave the company a “buy” rating in a report on Thursday, March 5th. Two analysts have rated the stock with a Strong Buy rating, seven have given a Buy rating, one has assigned a Hold rating and two have issued a Sell rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $43.44.

Key Stories Impacting Liquidia

Here are the key news stories impacting Liquidia this week:

• Positive Sentiment: Earnings beat and improving near‑term fundamentals — Liquidia reported stronger‑than‑expected revenue and EPS for the quarter (revenue and EPS beat consensus), which supports upside vs. expectations and likely underpins buying momentum. MarketBeat: Liquidia Stock
• Positive Sentiment: Analyst support — multiple firms have reiterated or raised ratings/targets (including upgrades and higher price targets), giving institutional and retail buyers a constructive research backdrop. MarketBeat: Analyst Coverage
• Neutral Sentiment: High institutional ownership (~64.5%) and selective inflows — large holders can stabilize the stock, so insider sales don’t automatically translate into sustained selling pressure if institutions hold or add. MarketBeat: Institutional Holdings
• Negative Sentiment: Concentrated insider selling — several executives sold meaningful blocks of shares (CEO and CFO among them) under pre‑arranged Rule 10b5‑1 plans; the scale and timing of these sales can create negative investor perception despite being planned. SEC Filing: Kaseta Sale
• Negative Sentiment: CEO/C-suite sales add to concern — CEO Roger Jeffs disclosed multi‑date sales (including a 25,000‑share block), which, together with other officer transactions, may cap upside near recent highs. SEC Filing: Jeffs Sale

Liquidia Company Profile

Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.

The company’s lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).